Oxbryta Sickle Cell Drug Recall: What You Need to Know
Segal Law is investigating legal cases on behalf of individuals who have taken Oxbryta (Voxelotor) to treat sickle cell anemia and have experienced severe side effects. If you or a loved one suffered from an increase in vaso-occlusion crisis events or a fatal outcome while using Oxbryta, you may be entitled to compensation.
FDA Announces Oxbryta Drug Recall
On September 26, 2024, the U.S. Food & Drug Administration (FDA) announced that Pfizer, Inc., had voluntarily recalled Oxbryta due to safety concerns. Oxbryta was initially approved by the FDA in 2019 for adults and children 12 years and older with sickle cell disease. In 2021, the approval was expanded to include patients aged 4 to 11 years.
Pfizer acknowledged that recent data showed the risks of Oxbryta outweighed its benefits for sickle cell patients. Patients taking the drug had a higher rate of vaso-occlusion crisis and mortality compared to those taking a placebo. The recall aims to protect individuals from these serious health risks.
How Oxbryta Puts Patients at Risk
Sickle cell disease is already a painful and life-threatening condition. Patients rely on medications like Oxbryta to help manage their symptoms and improve their quality of life. However, recent findings indicate that instead of helping, Oxbryta may be making their condition worse.
The primary risks associated with Oxbryta include:
Increased Vaso-Occlusion Crisis Events: Patients experienced more frequent and severe episodes of blocked blood flow, leading to extreme pain and potential organ damage.
Higher Mortality Rates: Studies found that more patients taking Oxbryta suffered fatal outcomes compared to those taking a placebo.
These alarming findings led to Pfizer’s decision to withdraw the drug from the market.
Holding Pfizer Accountable
Pfizer’s recall of Oxbryta highlights the need for pharmaceutical companies to conduct thorough testing and ensure patient safety before bringing a drug to market. Segal Law believes that Pfizer rushed the approval process for Oxbryta without adequately understanding the potential risks.
If you or someone you love has suffered harm due to Oxbryta, you have legal options. The experienced attorneys at Segal Law are ready to:
Investigate your case and gather evidence
Hold Pfizer accountable for failing to warn patients about the dangers of Oxbryta
Seek compensation for medical expenses, pain and suffering, and other damages
What to Do If You Took Oxbryta
If you are currently taking Oxbryta, consult with your doctor immediately to discuss whether you should discontinue use. It is important to monitor your health and report any adverse symptoms to a medical professional.
If you have already suffered complications due to Oxbryta, Segal Law can help. Our attorneys have extensive experience handling defective drug cases and will fight to get you the justice and compensation you deserve.
Contact Segal Law Today
If you or a loved one has been affected by the Oxbryta recall, don’t wait to take action. We are here to help you understand your legal rights and guide you through the process of seeking justice. Call us now to learn more about how we can assist you. Your health and well-being are our top priority. Contact Segal Law today for a free consultation.